Experiment 488694
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | LYNCH JR,TJ: KALISH,L: STRAUSS,G: FLIAS,A: SKARIN,A: SHULMAN,LN: POSNER,M: FREI III,E:. (1994). PHASE II STUDY OF TOPOTECAN IN METASTATIC NON-SMALL-CELL LUNG CANCER.. 12(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN THIS PHASE II STUDY 20 PREVIOUSLY UNTREATED PATIENTS WITH NON-SMALL-CELL LUNG CANCER WERE USED. PATIENTS WERE TREATED EVERY 21 DAYS FOR 5 DAYS FOR A MANIMUM OF 2 CYCLES. 2 PATIENTS SHOWED STABLE DISEASE AND 9 HAD PROGRESSION OF DISEASE. TOXICITIES INCLUDED NEUTROPENIA AND RASH. |
| Dose amount | 2.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |